$3.91
0.041.03%
al cierre: Aug 18, 5:00 PM EST
$3.79
-0.08-2.07%
Premercado: 7:04 AM EST
Fulcrum Therapeutics Inc
FULCNASDAQ
Fusiones y adquisiciones: Slate Medicines, Inc. announced it will be merged with Fulcrum Therapeutics (FULC) on Monday, August 17, 2026
Fulcrum Therapeutics Ownership & Insider Activity
Fulcrum Therapeutics (FULC) institutional and insider ownership, recent insider transactions and ownership breakdown.
Insiders own 1.4% of shares outstanding. Institutional investors hold 26.5%. Over the past 90 days, insiders made 2 purchases worth $1.5M and 1 sale worth $66K.
Shares Outstanding
76.297M
Shares Float
75.512M
Insider Shares Owned
1.104M
Insider % Owned
1.4%
Institutional Shares Held
20.212M
Institutional % Held
26.5%
Ownership Breakdown
Net Insider Activity by Month
Purchases (90d)
2
$1.5M total
Sales (90d)
1
$66K total
Net Activity
Net Buying
Net Value (90d)
$1.4M